DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.05 Bil PE Ratio: 47.26 PB Ratio: 15.58 GF Score: 74/100

Dexcom Inc at Raymond James Institutional Investors Conference Transcript

Mar 07, 2023 / 08:25PM GMT
Release Date Price: R$11.92
Jayson Tyler Bedford
Raymond James & Associates, Inc., Research Division - MD & Senior Medical Supplies and Devices Analyst

All right. Good afternoon. I think we'll get started. Thank you, and welcome to the 44th Annual Raymond James Institutional Investors Conference. I think there's a couple of seats up front if you guys are looking. But my name is Jayson Bedford. I cover the medical technology sector. And it's really our pleasure to have with us Dexcom who's been a loyal participant at this conference for many, many years, even when the market cap was much, much smaller. So congrats on all the success.

With that, we have the company's CFO, Jereme Sylvain. So with that, I'll pass it off.

Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO

Thank you, Jayson. Appreciate it. Thanks to everybody that come out and spend a little time with us today. We'll cover a little bit about the background of the organization, just where we're going -- where we've been, where we're going and a few different angles as to where the organization you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot